Portfolio (Quarterly)
Guide ↗
Velan Capital Investment Management LP
· CIK 0001848809| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | SUTRO BIOPHARMA INC | — | 512,160.0 | $12.8M | 7.99% | +200K | +64.2% | $24.91 | — |
| 2 | — | TENAX THERAPEUTICS INC | — | 583,333.0 | $9.3M | 5.84% | +500K | +600.0% | $15.99 | — |
| 3 | ABVX | ABIVAX SA | Healthcare | 77,000.0 | $8.6M | 5.37% | +10K | +14.9% | $111.35 | +9.6% |
| 4 | IMMX | IMMIX BIOPHARMA INC | Healthcare | 740,000.0 | $6.7M | 4.22% | +705K | +2014.3% | $9.11 | -3.6% |
| 5 | ESPR | ESPERION THERAPEUTICS INC NE | Healthcare | 1,720,000.0 | $4.7M | 2.95% | +510K | +42.1% | $2.74 | +14.2% |
| 6 | — | EDESA BIOTECH INC | — | 827,500.0 | $4.3M | 2.71% | +140K | +20.4% | $5.23 | — |
| 7 | CTMX | CYTOMX THERAPEUTICS INC. | Healthcare | 540,000.0 | $2.5M | 1.59% | +460K | +575.0% | $4.70 | -20.0% |
| 8 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 91,123.0 | $1.8M | 1.12% | +5K | +5.3% | $19.56 | -11.9% |
| 9 | — | CORBUS PHARMACEUTICALS HLDGS | — | 26,000.0 | $244K | 0.15% | +13K | +100.0% | $9.39 | — |
| 10 | — | PRECISION BIOSCIENCES INC | — | 40,000.0 | $220K | 0.14% | +20K | +100.0% | $5.50 | — |
| 11 | REPL | REPLIMUNE GROUP INC | Healthcare | 20,000.0 | $153K | 0.10% | +5K | +33.3% | $7.65 | -35.8% |
| 12 | PMVP | PMV PHARMACEUTICALS INC | Healthcare | 73,000.0 | $91K | 0.06% | +38K | +108.6% | $1.24 | +1.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%